News
Parkinson’s disease affects more than 10 million people worldwide. Discover its causes, symptoms, and the latest innovations ...
Only a handful of stem cell therapies are currently approved by the F.D.A., mainly for treating blood cancer and immune ...
Stem cells can fight disease from the inside out. But spas and clinics are selling treatments that are unproven, expensive, ...
CIA chief: We released two Mandarin-speaking videos to the Chinese people to contact us over dark web ...
2d
Pharmaceutical Technology on MSNFDA approves Capsida’s CAP-003 gene therapy for Parkinson’sThe FDA has approved Capsida Biotherapeutics' investigational new drug (IND) application for CAP-003 to treat Parkinson’s ...
An estimated 8,000 people in Singapore live with the disease. Read more at straitstimes.com. Read more at straitstimes.com.
11d
Vietnam Investment Review on MSNXellSmart gains FDA clearance for three iPSC cell therapiesXellSmart has completed multiple cases of iPSC-derived dopaminergic neural progenitor cell therapy for patients with ...
This first-in-human trial is testing a highly unconventional method: delivering fat-derived stem cells from the patient ...
On a special episode (first released on May 29, 2025) of The Excerpt podcast: Parkinson’s is a disease that afflicts an estimated 90,000 Americans every year. Dr. Lorenz Studer and Dr. Viviane ...
Aspen Neuroscience, Inc. announced its participation in "Illuminating the Future," the International Society for Stem Cell ...
Discover how Bayer and BlueRock are redefining biotech partnerships. From breakthrough Parkinson’s therapies to a unique “arm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results